NASDAQ: MGRX
Mangoceuticals Inc Stock

$2.50-0.04 (-1.57%)
Updated Dec 9, 2024
MGRX Price
$2.50
Fair Value Price
N/A
Market Cap
$6.22M
52 Week Low
$2.10
52 Week High
$16.80
P/E
-0.44x
P/B
0.46x
P/S
9.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$755.00k
Earnings
-$9.33M
Gross Margin
58.6%
Operating Margin
-1,172.86%
Profit Margin
-1,235.2%
Debt to Equity
0.11
Operating Cash Flow
-$5M
Beta
-0.07
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MGRX Overview

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MGRX's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

F
Value
C
Growth
F
Momentum
C
Sentiment
C
Safety
F
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
C
MGRX
Ranked
#49 of 52

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$4.34A
$47.10A
$14.79B
View Top Health Information Service Stocks

Be the first to know about important MGRX news, forecast changes, insider trades & much more!

MGRX News

Overview

Due Diligence Score

–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MGRX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MGRX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MGRX is good value based on its book value relative to its share price (0.46x), compared to the US Health Information Services industry average (3.86x)
P/B vs Industry Valuation
MGRX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MGRX due diligence checks available for Premium users.

Valuation

MGRX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.44x
Industry
24.56x
Market
29.44x

MGRX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.46x
Industry
3.86x
MGRX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MGRX's financial health

Profit margin

Revenue
$133.4k
Net Income
-$2.0M
Profit Margin
-1,499%
MGRX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MGRX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$14.8M
Liabilities
$1.4M
Debt to equity
0.11
MGRX's short-term liabilities ($1.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MGRX's short-term assets ($104.07k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MGRX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
$0.0
Financing
$750.0k
MGRX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MGRX vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MGRXD$6.22M-1.57%-0.44x0.46x
ZCMDC$5.48M+24.40%-0.82x0.31x
OTRKD$7.00M+1.22%0.14x0.61x
HCTIC$5.38M-19.49%-0.44x-2.96x
ICCT–$4.50M+10.78%-0.06x-1.49x

Mangoceuticals Stock FAQ

What is Mangoceuticals's quote symbol?

(NASDAQ: MGRX) Mangoceuticals trades on the NASDAQ under the ticker symbol MGRX. Mangoceuticals stock quotes can also be displayed as NASDAQ: MGRX.

If you're new to stock investing, here's how to buy Mangoceuticals stock.

What is the 52 week high and low for Mangoceuticals (NASDAQ: MGRX)?

(NASDAQ: MGRX) Mangoceuticals's 52-week high was $16.80, and its 52-week low was $2.10. It is currently -85.12% from its 52-week high and 19.05% from its 52-week low.

How much is Mangoceuticals stock worth today?

(NASDAQ: MGRX) Mangoceuticals currently has 2,486,512 outstanding shares. With Mangoceuticals stock trading at $2.50 per share, the total value of Mangoceuticals stock (market capitalization) is $6.22M.

Mangoceuticals stock was originally listed at a price of $60.00 in Mar 21, 2023. If you had invested in Mangoceuticals stock at $60.00, your return over the last 1 years would have been -95.83%, for an annualized return of -95.83% (not including any dividends or dividend reinvestments).

How much is Mangoceuticals's stock price per share?

(NASDAQ: MGRX) Mangoceuticals stock price per share is $2.50 today (as of Dec 9, 2024).

What is Mangoceuticals's Market Cap?

(NASDAQ: MGRX) Mangoceuticals's market cap is $6.22M, as of Dec 10, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mangoceuticals's market cap is calculated by multiplying MGRX's current stock price of $2.50 by MGRX's total outstanding shares of 2,486,512.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.